在严重的COPD恶化中使用葡萄糖皮质类药物治疗:生物学理由,临床影响和实际建议
Filippo Sartori1, Giulia Sartori1, Claudia Di Chiara1
1Department of Medicine, Respiratory Medicine Unit, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
Seminars in respiratory and critical care medicine
|September 16, 2025
概括
系统性皮质类固醇有效地通过减少炎症来治疗严重的慢性阻塞性肺病恶化. 血中乙氨基酸细胞计数可以指导个性化皮质类固醇治疗,以获得COPD患者更好的治疗结果.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学 是一个学科.
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (AECOPD) 的急性恶化造成了重大的临床负担.
- 系统性皮质类固醇是AECOPD的主要治疗方法,可以改善康复并减少住院时间.
- 皮质类固醇通过降低细胞因子和恢复葡萄糖皮质类固醇受体功能来产生抗炎作用.
研究的目的:
- 审查关于在严重AECOPD中使用皮质类固醇的证据.
- 强调基于临床和生物标志物数据的个性化治疗策略.
- 讨论未来在COPD恶化中优化皮质类固醇治疗的方向.
主要方法:
- 现有证据的叙述性审查.
- 药理学,临床和生物标志物引导方法的综合.
- 随机对照试验和元分析的分析.
主要成果:
- 短期,低至中等剂量的皮质类固醇是有效的,并最大限度地减少不良影响.
- 对大多数住院患者来说,口服治疗与静脉注射疗法一样有效.
- 血中乙氨基酸细胞的计数可以预测皮质类固醇反应,指导个性化治疗.
结论:
- 个性化皮质类固醇治疗,以炎症特征为指导,如乙氨基酸细胞计数,对于优化严重AECOPD的结果至关重要.
- 需要进一步的研究来确定最佳的治疗方案,完善生物标志物值,并扩大对重症患者的治疗方案.
- 皮质类固醇管理对于高风险COPD患者的个性化护理至关重要.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
737
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
737
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K


